The Promotion of Drug Innovation in Italy: Critical Aspects and Unsolved Problems-Reference-Cited by-同舟云学术

The Promotion of Drug Innovation in Italy: Critical Aspects and Unsolved Problems

Published:2016-01 Issue:1 Volume:3 Page:GRHTA.5000216
ISSN:2284-2403
Container-title:Global & Regional Health Technology Assessment
language:en
Short-container-title:Global & Regional Health Technology Assessment

Author:

Mennini Francesco S.¹²,Gitto Lara¹,Scrivo Roberto³,Drago Filippo⁴,Iezzi Marco⁵,Terranova Lorenzo⁶,Ruggeri Matteo⁷,Marcellusi Andrea¹,Russo Simone¹,Viti Raffaella¹,Cicchetti Americo⁷

Affiliation:

1. CEIS EEHTA (Economic Evaluation & HTA), Università di Roma “Tor Vergata”, Roma - Italy

2. Institute of Leadership and Management, Kingston University, London - UK

3. Ministero della Salute, Roma - Italy

4. Università di Catania, Dipartimento di Scienze Biomediche e Biotecnologiche, Catania - Italy

5. European Commission, DG ECFIN - A4 Economic situation, forecasts, business and consumer surveys, Bruxelles - Belgium

6. Federsanità ANCI, Roma - Italy

7. ALTEMS, Università Cattolica del Sacro Cuore, Roma - Italy

Publisher

Aboutscience Srl

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.5301/GRHTA.5000216

Reference8 articles.

3. Key principles for the improved conduct of health technology assessments for resource allocation decisions

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INVESTING IN INNOVATION: THE RELATIONSHIP BETWEEN R&D SPENDING AND FINANCIAL PERFORMANCE IN THE EUROPEAN PHARMACEUTICAL INDUSTRY;J E EUR CENT ASIAN R;2023

2. Contemporary challenges in the European pharmaceutical industry: a systematic literature review;Measuring Business Excellence;2022-11-08